Skip to main content

and
  1. No Access

    Article

    Hypoxia inducible factor-prolyl hydroxylase inhibitors in anemic patients with non-dialysis dependent chronic kidney disease: a meta-analysis of randomized clinical trials

    Anemia persists as a challenge in chronic kidney disease (CKD) patients. Current therapies are the injectable erythropoietin stimulating agents (ESA). Concerns have been raised regarding ESA cardiovascular saf...

    Mohamed M. G. Mohamed, Mosunmoluwa Oyenuga in International Urology and Nephrology (2023)